Stock comparison
McKesson
United Therapeutics
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
MCK
McKesson
Market cap
$92.09B
Sector
Healthcare
UTHR
United Therapeutics
Market cap
$24.13B
Sector
Healthcare
Overall winner
United Therapeutics UTHR
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | MCK | UTHR | Winner |
|---|---|---|---|
| Warren Buffett | 63C | 71B | UTHR |
| Benjamin Graham | 51C | 76B | UTHR |
| Philip Fisher |
Side-by-side metrics
| Metric | MCK | UTHR |
|---|---|---|
| Market cap | $92.09B | $24.13B |
| P/E (TTM) | 19.5x | 19.2x |
| EV/EBIT | 14.9x | 15.2x |
| ROIC (TTM) | 31.07% | 18.81% |
| Gross margin | 3.61% | 86.58% |
| Net margin | 1.18% | 40.61% |
| Revenue CAGR 5y | 11.19% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
MCK leads on
- Debt / Equity-vs -+100%
- Dividend yield0.42%vs 0.0%+100%
- Market cap$92.09Bvs $24.13B+74%
- EPS CAGR 5y51.54%vs 29.84%
More like UTHR
Related on invest-like
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.